Dr Norrie Russell joins NovaRx
This article was originally published in Scrip
The US biopharmaceutical company NovaRx has named Dr Norrie Russell president and chief operating officer. He has more than 25 years' experience in drug discovery, having previously served as president and CEO of the biotech company Kalos Therapeutics. Dr Russell has also worked at AstraZeneca, Invitrogen, Aviva Biosciences and Lynx Therapeutics.